Found 11 matching trials
Evaluation of Immune Memory to Twinrix or Comparator by Challenge Dose Administration 4 Years After Primary Vaccination
PHASE4Only subjects who participated in the primary study will be invited to part...
Location
GSK Investigational Site
Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Month Schedule
PHASE3The aim of this study is to evaluate the long-term persistence of hepatitis...
Location
GSK Investigational Site
Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,6 Month Schedule
PHASE3The aim of this study is to evaluate the long-term persistence of hepatitis...
Location
GSK Investigational Site
Long-term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Mth Schedule in Healthy Adults
PHASE3The aim of this study is to evaluate the long-term persistence of hepatitis...
Location
GSK Investigational Site
Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus Vaccine With Another Vaccine in Healthy Female Subjects
PHASE3Infection with human papillomavirus (HPV) has been clearly established as t...
Location
GSK Investigational Site
Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B Vaccine
PHASE3To evaluate the persistence of immune response 5 years and 6 years after th...
Location
GSK Investigational Site
Evaluation of Antibody Persistence & Immune Memory in Subjects Vaccinated During Adolescence With Twinrix™
PHASE4This study will evaluate the immune response against Hepatitis-A (HAV) and ...
Location
GSK Investigational Site
Long Term Follow-up Study at Years 2, 3, 4 and 5 Where 2 Dosing Schedules of the Combined Hepatitis A and B Vaccine Were Compared
PHASE3To evaluate the persistence of anti-hepatitis A virus (HAV) and anti-hepati...
Location
GSK Investigational Site
Primary Study to Demonstrate Non-inferiority and Immunogenicity of GSK Biologicals' Meningococcal Vaccine 134612
PHASE3This study will demonstrate the non-inferiority of GSK Biologicals' meningo...
Location
GSK Investigational Site
Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B Vacc
PHASE4The focus of this study is to evaluate how risk factors like age, gender, b...
Location
GSK Investigational Site